Robin Roberts, COO and co-founder of the Novartis Biome, was on site at JP Morgan last month in San Francisco, but we weren’t able to pin him down for an interview.
Fresh from reporting encouraging results with its oral weight-loss drug, Terns Pharma has moved swiftly ahead with a public offering, seeking to raise upwards of $125 million to fund additi